Sanofi Earnings Driven by New Medicine Sales, Dupixent Performance
Sanofi(US:SNY) WSJ·2025-10-24 14:55公司业绩表现 - 第三季度净销售额增长7% [1] - 增长由新药上市和重磅药物Dupixent需求增加推动 [1]
Sanofi(US:SNY) WSJ·2025-10-24 14:55Sanofi(US:SNY) WSJ·2025-10-24 14:55Sanofi(US:SNY) WSJ·2025-10-24 14:55公司业绩表现 - 第三季度净销售额增长7% [1] - 增长由新药上市和重磅药物Dupixent需求增加推动 [1]